📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Stromedix

1.1 - Company Overview

Stromedix Logo

Stromedix

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drugs targeting fibrosis, organ failure, and cancer, initially focused on chronic indications, with plans to expand into related settings such as acute organ failure and cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Stromedix

Sitryx Logo

Sitryx

HQ: United Kingdom Website
  • Description: Provider of cell metabolism–targeted, first-in-class, disease-modifying therapeutics in immuno-oncology and immuno-inflammation. Pipeline includes SYX-5219 for atopic dermatitis; SIT-052, an inhaled GLS1 inhibitor for pulmonary fibrosis and COPD that selectively breaks down senescent cells; SIT-033, a SIK2 inhibitor for ulcerative colitis; and SYX-1042 and SIT-047 for autoimmune indications (with Eli Lilly).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sitryx company profile →
Viela Bio Logo

Viela Bio

HQ: United States Website
  • Description: Provider of clinical-stage treatments for severe inflammation and autoimmune diseases, with a portfolio that selectively targets shared critical pathways at the root cause of disease; led by global leaders in inflammation and autoimmunity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viela Bio company profile →
vTv Therapeutics Logo

vTv Therapeutics

HQ: United States Website
  • Description: Provider of small-molecule therapeutics addressing unmet medical needs, including: TTP399, a liver-selective glucokinase activator adjunct to insulin for type 1 diabetes to reduce hypoglycemia; HPP737, a PDE4 inhibitor for psoriasis with potential in COPD and atopic dermatitis; TTP273, an oral GLP-1 receptor agonist for type 2 diabetes; and a Nrf2/Bach1 program to reduce oxidative stress and inflammation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full vTv Therapeutics company profile →
Bryn Pharma Logo

Bryn Pharma

HQ: United States Website
  • Description: Provider of nasal-based epinephrine for anaphylaxis, including NDS1C, a needle-free, easy-to-use epinephrine nasal spray for the treatment of anaphylaxis. Also offers a Clinical Development Program focused on demonstrating the pharmacokinetic parameters and safety of NDS1C compared to the 0.3 mg IM epinephrine autoinjector.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bryn Pharma company profile →
180 Life Sciences Logo

180 Life Sciences

HQ: United States Website
  • Description: Provider of novel drug development focused on treating distinct inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 180 Life Sciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Stromedix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Stromedix

2.2 - Growth funds investing in similar companies to Stromedix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Stromedix

4.2 - Public trading comparable groups for Stromedix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Stromedix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Stromedix

What does Stromedix do?

Stromedix is a provider of drugs targeting fibrosis, organ failure, and cancer, initially focused on chronic indications, with plans to expand into related settings such as acute organ failure and cancer.

Who are Stromedix's competitors?

Stromedix's competitors and similar companies include Sitryx, Viela Bio, vTv Therapeutics, Bryn Pharma, and 180 Life Sciences.

Where is Stromedix headquartered?

Stromedix is headquartered in United States.

How many employees does Stromedix have?

Stromedix has 1,000 employees 🔒.

When was Stromedix founded?

Stromedix was founded in 2010 🔒.

What sector and industry vertical is Stromedix in?

Stromedix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Stromedix

Who are the top strategic acquirers in Stromedix's sector and industry

Top strategic M&A buyers and acquirers in Stromedix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Stromedix?

Top strategic M&A buyers groups and sectors for Stromedix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Stromedix's sector and industry vertical

Which are the top PE firms investing in Stromedix's sector and industry vertical?

Top PE firms investing in Stromedix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Stromedix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Stromedix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Stromedix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Stromedix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Stromedix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Stromedix?

The key public trading comparables and valuation benchmarks for Stromedix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Stromedix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Stromedix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Stromedix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Stromedix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Stromedix's' sector and industry vertical?

Access recent funding rounds and capital raises in Stromedix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Stromedix